Chemours names Shane Hostetter as CFO effective July 1, 2024

Chemours Co

Hostetter joins from Quaker Houghton, where he served as CFO since April 2021.
He receives $600k base salary, $50k signing bonus, 75% target bonus, $1M LTI target.
One-time grant of $500k RSUs vesting one-third per year over three years.
Interim CFO Matt Abbott returns to role of SVP & Chief Enterprise Transformation Officer.
Hostetter will lead Finance, IR, Corporate Development, Strategy, and Enterprise Risk Management.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Matthew Abbott

Senior Vice President & Chief Enterprise Transformation Officer

CC · Chemours Co

Effective: 2024-07-01
Filed: June 5, 2024, 7:59 PM ET

Mr. Hostetter succeeds Matthew Abbott, who has served as the Interim Chief Financial Officer (principal financial and accounting officer) since February 28, 2024. Mr. Abbott will continue serving as the Company’s Senior Vice President & Chief Enterprise Transformation Officer

Appointed

Shane Hostetter

Chief Financial Officer

CC · Chemours Co

Effective: 2024-07-01
Successor: Matthew Abbott
Filed: June 5, 2024, 7:59 PM ET

On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Abbott changed role as Senior Vice President & Chief Enterprise Transformation Officer at Chemours Co.

Action: will continue serving as
Role: Senior Vice President & Chief Enterprise Transformation Officer

Exact text from the filing

Mr. Hostetter succeeds Matthew Abbott, who has served as the Interim Chief Financial Officer (principal financial and accounting officer) since February 28, 2024. Mr. Abbott will continue serving as the Company’s Senior Vice President & Chief Enterprise Transformation Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Shane Hostetter was appointed as Chief Financial Officer at Chemours Co.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.

View on SEC.gov

Chemours Co filing history →

Source: SEC EDGAR

accession 0000950170-24-069063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.